Lipid Nanoparticles

Abstract Solid lipid nanoparticles (SLNs) exhibit excellent potential as a drug delivery system in treating several cancers including gastrointestinal (GI)...

Abstract Endometriosis (EM) is a gynaecological disorder for which drug combinations such as atorvastatin (ATV) and silybin (SB) hold therapeutic...

Abstract During the pandemic, lipid nanoparticles (LNPs) became widely established as RNA nanocarriers, and hold the promise of future targeting...

Abstract Effective buccal drug delivery is limited by the barrier properties of the mucosa, necessitating innovative systems to enhance permeability...

Abstract Cancer remains to be one of the most life-threatening diseases with high rates of mortality and morbidity. The major...

Abstract Lipid-based formulations (LBFs) play a crucial role in enhancing the oral bioavailability of poorly water-soluble drugs by leveraging lipid...

Abstract Hybrid lipid nanocapsules (hLNCs) represent a promising platform for mRNA delivery with the added benefit of ambient-temperature stabilization. Conventional...

Abstract Ezetimibe is a cholesterol absorption inhibitor widely used in the treatment of dyslipidemia. However, its clinical efficacy is limited...

Abstract Liver diseases—encompassing hepatitis, liver fibrosis, fatty liver, and hepatocellular carcinoma—constitute a formidable global health challenge. Existing treatments are often...

Abstract Lipid nanodispersions are a promising formulation strategy for improving the bioavailability of drugs that are poorly water-soluble but highly...